Atlas Trials

CD147-CART Cells in Patients With Recurrent Malignant Glioma.

Clinical trial NCT04045847 · UNKNOWN

Trial details

NCT number
NCT04045847
Sponsor
Xijing Hospital
Status
UNKNOWN
Phase
Early Phase 1
Study type
INTERVENTIONAL
Recurrent GlioblastomaCD147 Positive
Start date
2019-05-30
Primary completion
2020-10-30
Enrollment
31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.